메뉴 건너뛰기




Volumn 60, Issue SUPPL. 14, 1999, Pages 27-30

Management of sexual side effects of antidepressant therapy

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIURETIC AGENT; HALOPERIDOL; HISTAMINE H2 RECEPTOR ANTAGONIST; MIRTAZAPINE; NEFAZODONE; SEROTONIN UPTAKE INHIBITOR;

EID: 0032837648     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper
Times cited : (52)

References (15)
  • 2
    • 0020436320 scopus 로고
    • Sexual dysfunctions in depression
    • Matthew RJ, Weinman ML. Sexual dysfunctions in depression. Arch Sex Behav 1982;11:323-328
    • (1982) Arch Sex Behav , vol.11 , pp. 323-328
    • Matthew, R.J.1    Weinman, M.L.2
  • 3
    • 0031024652 scopus 로고    scopus 로고
    • Medications that may contribute to sexual disorders: A guide to assessment and treatment in family
    • Finger WW, Lund M, Slagle MA. Medications that may contribute to sexual disorders: a guide to assessment and treatment in family. J Fam Pract 1997;44:33-43
    • (1997) J Fam Pract , vol.44 , pp. 33-43
    • Finger, W.W.1    Lund, M.2    Slagle, M.A.3
  • 4
    • 0003984768 scopus 로고    scopus 로고
    • Montvale, NJ: Medical Economics
    • Physicians' Desk Reference. Montvale, NJ: Medical Economics 1998
    • (1998) Physicians' Desk Reference
  • 6
    • 0031002278 scopus 로고    scopus 로고
    • Comparative sexual side effects of bupropion, fluoxetine, paroxetine, and sertraline
    • Modell JG, Katholi CR, Modell JD, et al. Comparative sexual side effects of bupropion, fluoxetine, paroxetine, and sertraline. Clin Pharmacol Ther 1997;61:476-487
    • (1997) Clin Pharmacol Ther , vol.61 , pp. 476-487
    • Modell, J.G.1    Katholi, C.R.2    Modell, J.D.3
  • 8
    • 0029097135 scopus 로고
    • Selective serotonin reuptake inhibitor-induced sexual dysfunction: Efficacy of a drug holiday
    • Rothschild AJ. Selective serotonin reuptake inhibitor-induced sexual dysfunction: efficacy of a drug holiday. Am J Psychiatry 1995;152:1514-1516
    • (1995) Am J Psychiatry , vol.152 , pp. 1514-1516
    • Rothschild, A.J.1
  • 9
    • 0027858193 scopus 로고
    • Improvement in fluoxetine-associated sexual dysfunction in patients switched to bupropion
    • Walker PW, Cole JO, Gardner EA, et al. Improvement in fluoxetine-associated sexual dysfunction in patients switched to bupropion. J Clin Psychiatry 1993;54:459-465
    • (1993) J Clin Psychiatry , vol.54 , pp. 459-465
    • Walker, P.W.1    Cole, J.O.2    Gardner, E.A.3
  • 10
    • 0000548262 scopus 로고    scopus 로고
    • Mirtazapine substitution in SSRI-induced sexual dysfunction
    • Gelenberg AJ, Laukes C, McGahuey C, et al. Mirtazapine substitution in SSRI-induced sexual dysfunction [abstract]. Biol Psychiatry 1998;43:104S
    • (1998) Biol Psychiatry , vol.43
    • Gelenberg, A.J.1    Laukes, C.2    McGahuey, C.3
  • 11
    • 0029871175 scopus 로고    scopus 로고
    • Nefazodone versus sertraline in outpatients with major depression: Focus on efficacy, tolerability, and effects on sexual function and satisfaction
    • Feiger A, Kiev A, Shrivastava RK, et al. Nefazodone versus sertraline in outpatients with major depression: focus on efficacy, tolerability, and effects on sexual function and satisfaction. J Clin Psychiatry 1996;57 (suppl 2):53-62
    • (1996) J Clin Psychiatry , vol.57 , Issue.2 SUPPL. , pp. 53-62
    • Feiger, A.1    Kiev, A.2    Shrivastava, R.K.3
  • 12
    • 0029786469 scopus 로고    scopus 로고
    • Recovery after 5 years of unremitting major depressive disorder
    • Mueller TI, Keller MB, Leon AC, et al. Recovery after 5 years of unremitting major depressive disorder. Arch Gen Psychiatry 1996;53:794-799
    • (1996) Arch Gen Psychiatry , vol.53 , pp. 794-799
    • Mueller, T.I.1    Keller, M.B.2    Leon, A.C.3
  • 13
    • 0031669033 scopus 로고    scopus 로고
    • Optimal length of continuation therapy in depression: A prospective assessment during longterm fluoxetine treatment
    • Reimherr FW, Amsterdam JD, Quitkin FM, et al. Optimal length of continuation therapy in depression: a prospective assessment during longterm fluoxetine treatment. Am J Psychiatry 1998;155:1247-1253
    • (1998) Am J Psychiatry , vol.155 , pp. 1247-1253
    • Reimherr, F.W.1    Amsterdam, J.D.2    Quitkin, F.M.3
  • 14
    • 0028020276 scopus 로고
    • Natural history and heterogeneity of depressive disorders: Implications for rational antidepressant therapy
    • Keller MB, Hanks DL. Natural history and heterogeneity of depressive disorders: implications for rational antidepressant therapy. J Clin Psychiatry 1994;55(9, suppl A):25-31
    • (1994) J Clin Psychiatry , vol.55 , Issue.9 SUPPL. A , pp. 25-31
    • Keller, M.B.1    Hanks, D.L.2
  • 15
    • 0025331841 scopus 로고
    • Relapse and recurrence in unipolar major depression: Short-term and long-term approaches
    • Thase ME. Relapse and recurrence in unipolar major depression: short-term and long-term approaches. J Clin Psychiatry 1990;51(6, suppl):51-57
    • (1990) J Clin Psychiatry , vol.51 , Issue.6 SUPPL. , pp. 51-57
    • Thase, M.E.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.